Jaysynth Orgo

Market Cap: Micro Cap
Industry: Specialty Chemicals
ISIN: INE263B01022
NSEID: JDORGOCHEM
BSEID: 524592

INR

14.80

-0.2 (-1.33%)

BSENSE

Dec 24

BSE+NSE Vol: 6.35 k

{
  "main_header": {
    "sid": 275488,
    "name": "Jaysynth Orgo",
    "stock_name": "Jaysynth Orgo",
    "full_name": "Jaysynth Orgochem Ltd",
    "name_url": "stocks-analysis/jaysynth-orgo",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.80",
    "chg": -0.2,
    "chgp": "-1.33%",
    "dir": -1,
    "prev_price": "15.00",
    "mcapval": "204.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524592,
    "symbol": "JDORGOCHEM",
    "ind_name": "Specialty Chemicals",
    "ind_code": 84,
    "indexname": "",
    "isin": "INE263B01022",
    "curr_date": "Dec 24",
    "curr_time": "",
    "bse_nse_vol": "6.35 k",
    "exc_status": "Active",
    "traded_date": "Dec 24, 2025",
    "traded_date_str": "2025 12 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jaysynth-orgo-275488-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Jaysynth Orgo falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jaysynth-orgo-fallingrising-3761636",
        "imagepath": "",
        "date": "2025-12-18 00:41:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock has been on a downward trajectory, losing value for three consecutive days and registering a cumulative fall of 3.87% during this period. Over the past week, Jaysynth Orgochem’s shares declined by 2.33%, contrasting with the Sensex’s modest gain of 0.20%. The underperformance extends over longer horizons as well, with the stock falling 14.92% in the last month compared to a marginal 0.46% decline in the Sensex. Year-to-date, the stock has plummeted 47.42%, while the benchmark index has risen by 8.22%. Even over the last year, Jaysynth Orgochem’s shares have dropped 43.33%, whereas the Sensex gained 4.80%.</p>\n<p>This stark divergence highlights the stock’s struggles relative to the broader market, signalling investor conce..."
      },
      {
        "title": "Jaysynth Orgo Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jaysynth-orgo-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-signals-3746500",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JaysynthOrgo_mojoScore_3746500.png",
        "date": "2025-12-04 11:08:19",
        "description": "Jaysynth Orgo, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. The recent assessment highlights a combination of flat financial trends and bearish technical signals, set against a backdrop of underwhelming stock performance over the past year."
      },
      {
        "title": "Is Jaysynth Orgo overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jaysynth-orgo-overvalued-or-undervalued-3739815",
        "imagepath": "",
        "date": "2025-12-02 08:08:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Attractiveness</strong></p>\n<p>At a price-to-earnings (PE) ratio of approximately 12.5, Jaysynth Orgo trades at a discount compared to many of its industry peers, some of which exhibit PE ratios several times higher. This relatively low PE ratio suggests the stock is priced modestly relative to its earnings, a key indicator that the market may be undervaluing the company’s profitability. Additionally, the price-to-book value stands at 1.64, reflecting a reasonable premium over the company’s net asset value, which aligns with a fair to attractive valuation stance.</p>\n<p>The enterprise value to EBITDA (EV/EBITDA) ratio of 10.0 further supports this view, indicating that the company’s earnings before interest, taxes, depreciation, and amortisation are being valued co..."
      },
      {
        "title": "Why is Jaysynth Orgo falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jaysynth-orgo-fallingrising-3708114",
        "imagepath": "",
        "date": "2025-11-17 21:25:18",
        "description": "As of 17-Nov, Jaysynth Orgochem Ltd's stock price is currently at 17.06, reflecting a decline of 0.58, or 3.29%. The stock has been underperforming recently, having fallen for the last two days, resulting in a total drop of 7.48% during this period. Although the stock has shown positive returns over the past week and month, with increases of 11.07% and 6.76% respectively, it has significantly underperformed year-to-date with a decline of 38.77%. Additionally, the stock's delivery volume has decreased by 17.58% compared to the 5-day average, indicating a drop in investor participation, which may contribute to the recent price decline. There is no information available regarding positive or negative factors impacting the stock.\n\nBroader market context indicates that while Jaysynth Orgochem Ltd has experienced a strong performance over the long term, with a 3-year return of 105.54% and a 5-year return of 470.5..."
      },
      {
        "title": "Is Jaysynth Orgo overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jaysynth-orgo-overvalued-or-undervalued-3700041",
        "imagepath": "",
        "date": "2025-11-14 08:07:54",
        "description": "As of 13 November 2025, the valuation grade for Jaysynth Orgo has moved from very attractive to fair. Based on the current analysis, the company appears to be fairly valued. Key ratios include a PE ratio of 15.31, an EV to EBITDA of 12.02, and a PEG ratio of 0.19, which indicates a strong growth potential relative to its price.\n\nWhen compared to peers, Jaysynth Orgo's PE ratio is significantly lower than Sudarshan Chemical's 138.83, while being more favorable than Kiri Industries' risky valuation at 25.78. Additionally, the company has a ROCE of 13.60% and a ROE of 13.04%, suggesting efficient use of capital compared to its peers. Notably, despite a recent decline in stock performance year-to-date, where it has returned -34.13% compared to the Sensex's 8.11%, the long-term performance over five years shows a remarkable increase of 513.71%, reinforcing the potential for recovery and growth in the specialty c..."
      },
      {
        "title": "Why is Jaysynth Orgo falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jaysynth-orgo-fallingrising-3698458",
        "imagepath": "",
        "date": "2025-11-13 21:31:50",
        "description": "As of 13-Nov, Jaysynth Orgochem Ltd's stock price is currently at Rs 18.35, reflecting an increase of Rs 2.24, or 13.9%. The stock has been on a positive trajectory, gaining for the last three days with a total return of 19.47% during this period. It opened today with a gain of 2.79% and reached an intraday high of Rs 19, indicating strong upward momentum. The stock has outperformed its sector by 12.4% today and has shown significant volatility with an intraday volatility of 7.04%. Additionally, the stock's performance over the past week has been impressive, with a return of 18.08%, while its year-to-date performance remains negative at -34.13%. Notably, there is a rising investor participation, as evidenced by a 65.93% increase in delivery volume compared to the 5-day average.\n\nIn the broader market context, the Sensex has only increased by 1.40% over the past week, highlighting that Jaysynth Orgochem Ltd'..."
      },
      {
        "title": "Are Jaysynth Orgo latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jaysynth-orgo-latest-results-good-or-bad-3698233",
        "imagepath": "",
        "date": "2025-11-13 19:24:02",
        "description": "JD Orgochem's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported a consolidated net profit of ₹4.95 crores, reflecting a significant recovery from the previous quarter's decline, marking a 187.79% increase quarter-on-quarter. This recovery is accompanied by a notable revenue growth of 11.51%, bringing total revenue to ₹65.80 crores, which is the highest quarterly sales figure in recent history. The operating margin also improved to 9.70%, up from 6.29% in the previous quarter, indicating enhanced operational efficiency.\n\nDespite these positive trends in revenue and profit margins, JD Orgochem faces challenges with a weak return on equity (ROE) of just 3.05%, which is considerably lower than its peers in the specialty chemicals sector. This low ROE raises concerns about the company's ability to generate value for shareholders effectively. Additiona..."
      },
      {
        "title": "Jaysynth Orgochem Shows Financial Resilience Amid Mixed Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jaysynth-orgochems-financial-trend-improves-from-negative-to-flat-amid-increased-net-sales-3697330",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JaysynthOrgoche_fintrenddot_3697330.png",
        "date": "2025-11-13 11:01:02",
        "description": "Jaysynth Orgochem, a microcap in the specialty chemicals sector, reported improved quarterly results for September 2025, with net sales of Rs 65.80 crore and a profit after tax of Rs 4.95 crore, reflecting strong growth. However, operating cash flow has decreased, indicating cash generation challenges. The company has shown resilience in market performance."
      },
      {
        "title": "JD Orgochem Q2 FY26: Profit Surge Masks Underlying Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/jd-orgochem-q2-fy26-profit-surge-masks-underlying-concerns-3697631",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JaysynthOrgoche_quaterlyResult_3697631.png",
        "date": "2025-11-13 09:21:20",
        "description": "JD Orgochem Ltd., a micro-cap speciality chemicals manufacturer, reported a dramatic 187.79% quarter-on-quarter surge in net profit to ₹4.95 crores for Q2 FY26, rebounding from the disappointing ₹1.72 crores posted in Q1 FY26. However, the year-on-year growth remained modest at 16.75%, whilst the stock continues to languish 38.36% below its 52-week high of ₹29.20, reflecting persistent investor concerns about the company's structural challenges."
      }
    ],
    "total": 5953,
    "sid": "275488",
    "stock_news_url": "https://www.marketsmojo.com/news/jaysynth-orgochem-275488"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2025",
      "details": "Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we have published Extract of Un-audited Standalone and Consolidated Financial Results for the quarter and half financial year ended 30th September 2025 which appeared in Financial Express (English) all over India edition and Loksatta (Marathi) Mumbai edition on Thursday 13th November 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "12-Nov-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that Board of Directors of the Company at its Meeting held on Wednesday 12th November 2025 at the Registered Office of the Company at 301 Sumer Kendra P.B. Marg Worli Mumbai - 400 018 inter alia approved the following : 1. Un-audited Standalone and Consolidated Financial Results for the quarter and half financial year ended 30th September 2025 along with the Limited Review Report issued by M/s. A H J & Associates Chartered Accountants Statutory Auditor of the Company. 2. Standalone and Consolidated Statement of Assets and Liabilities for the half financial year ended 30th September 2025. 3. Standalone and Consolidated Cash Flow Statement for the half financial year ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Financial Results",
      "datetime": "12-Nov-2025",
      "details": "Un-audited Financial Results for the quarter and half financial year ended 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jaysynth Orgochem Ltd has declared <strong>5%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jaysynth Orgochem Ltd has announced <strong>1:10</strong> stock split, ex-date: 25 Jul 08",
          "dt": "2008-07-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Jaysynth Orgo falling/rising?

2025-12-18 00:41:03

Recent Price Movement and Market Comparison

The stock has been on a downward trajectory, losing value for three consecutive days and registering a cumulative fall of 3.87% during this period. Over the past week, Jaysynth Orgochem’s shares declined by 2.33%, contrasting with the Sensex’s modest gain of 0.20%. The underperformance extends over longer horizons as well, with the stock falling 14.92% in the last month compared to a marginal 0.46% decline in the Sensex. Year-to-date, the stock has plummeted 47.42%, while the benchmark index has risen by 8.22%. Even over the last year, Jaysynth Orgochem’s shares have dropped 43.33%, whereas the Sensex gained 4.80%.

This stark divergence highlights the stock’s struggles relative to the broader market, signalling investor conce...

Jaysynth Orgo Sees Revision in Market Evaluation Amidst Challenging Financial Trends

2025-12-04 11:08:19

Jaysynth Orgo, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. The recent assessment highlights a combination of flat financial trends and bearish technical signals, set against a backdrop of underwhelming stock performance over the past year.

Is Jaysynth Orgo overvalued or undervalued?

2025-12-02 08:08:15

Valuation Metrics Indicate Attractiveness

At a price-to-earnings (PE) ratio of approximately 12.5, Jaysynth Orgo trades at a discount compared to many of its industry peers, some of which exhibit PE ratios several times higher. This relatively low PE ratio suggests the stock is priced modestly relative to its earnings, a key indicator that the market may be undervaluing the company’s profitability. Additionally, the price-to-book value stands at 1.64, reflecting a reasonable premium over the company’s net asset value, which aligns with a fair to attractive valuation stance.

The enterprise value to EBITDA (EV/EBITDA) ratio of 10.0 further supports this view, indicating that the company’s earnings before interest, taxes, depreciation, and amortisation are being valued co...

Why is Jaysynth Orgo falling/rising?

2025-11-17 21:25:18

As of 17-Nov, Jaysynth Orgochem Ltd's stock price is currently at 17.06, reflecting a decline of 0.58, or 3.29%. The stock has been underperforming recently, having fallen for the last two days, resulting in a total drop of 7.48% during this period. Although the stock has shown positive returns over the past week and month, with increases of 11.07% and 6.76% respectively, it has significantly underperformed year-to-date with a decline of 38.77%. Additionally, the stock's delivery volume has decreased by 17.58% compared to the 5-day average, indicating a drop in investor participation, which may contribute to the recent price decline. There is no information available regarding positive or negative factors impacting the stock. Broader market context indicates that while Jaysynth Orgochem Ltd has experienced a strong performance over the long term, with a 3-year return of 105.54% and a 5-year return of 470.5...

Is Jaysynth Orgo overvalued or undervalued?

2025-11-14 08:07:54

As of 13 November 2025, the valuation grade for Jaysynth Orgo has moved from very attractive to fair. Based on the current analysis, the company appears to be fairly valued. Key ratios include a PE ratio of 15.31, an EV to EBITDA of 12.02, and a PEG ratio of 0.19, which indicates a strong growth potential relative to its price. When compared to peers, Jaysynth Orgo's PE ratio is significantly lower than Sudarshan Chemical's 138.83, while being more favorable than Kiri Industries' risky valuation at 25.78. Additionally, the company has a ROCE of 13.60% and a ROE of 13.04%, suggesting efficient use of capital compared to its peers. Notably, despite a recent decline in stock performance year-to-date, where it has returned -34.13% compared to the Sensex's 8.11%, the long-term performance over five years shows a remarkable increase of 513.71%, reinforcing the potential for recovery and growth in the specialty c...

Why is Jaysynth Orgo falling/rising?

2025-11-13 21:31:50

As of 13-Nov, Jaysynth Orgochem Ltd's stock price is currently at Rs 18.35, reflecting an increase of Rs 2.24, or 13.9%. The stock has been on a positive trajectory, gaining for the last three days with a total return of 19.47% during this period. It opened today with a gain of 2.79% and reached an intraday high of Rs 19, indicating strong upward momentum. The stock has outperformed its sector by 12.4% today and has shown significant volatility with an intraday volatility of 7.04%. Additionally, the stock's performance over the past week has been impressive, with a return of 18.08%, while its year-to-date performance remains negative at -34.13%. Notably, there is a rising investor participation, as evidenced by a 65.93% increase in delivery volume compared to the 5-day average. In the broader market context, the Sensex has only increased by 1.40% over the past week, highlighting that Jaysynth Orgochem Ltd'...

Are Jaysynth Orgo latest results good or bad?

2025-11-13 19:24:02

JD Orgochem's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported a consolidated net profit of ₹4.95 crores, reflecting a significant recovery from the previous quarter's decline, marking a 187.79% increase quarter-on-quarter. This recovery is accompanied by a notable revenue growth of 11.51%, bringing total revenue to ₹65.80 crores, which is the highest quarterly sales figure in recent history. The operating margin also improved to 9.70%, up from 6.29% in the previous quarter, indicating enhanced operational efficiency. Despite these positive trends in revenue and profit margins, JD Orgochem faces challenges with a weak return on equity (ROE) of just 3.05%, which is considerably lower than its peers in the specialty chemicals sector. This low ROE raises concerns about the company's ability to generate value for shareholders effectively. Additiona...

Jaysynth Orgochem Shows Financial Resilience Amid Mixed Performance Metrics

2025-11-13 11:01:02

Jaysynth Orgochem, a microcap in the specialty chemicals sector, reported improved quarterly results for September 2025, with net sales of Rs 65.80 crore and a profit after tax of Rs 4.95 crore, reflecting strong growth. However, operating cash flow has decreased, indicating cash generation challenges. The company has shown resilience in market performance.

JD Orgochem Q2 FY26: Profit Surge Masks Underlying Concerns

2025-11-13 09:21:20

JD Orgochem Ltd., a micro-cap speciality chemicals manufacturer, reported a dramatic 187.79% quarter-on-quarter surge in net profit to ₹4.95 crores for Q2 FY26, rebounding from the disappointing ₹1.72 crores posted in Q1 FY26. However, the year-on-year growth remained modest at 16.75%, whilst the stock continues to languish 38.36% below its 52-week high of ₹29.20, reflecting persistent investor concerns about the company's structural challenges.

View All News

Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2025 | Source : BSE

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we have published Extract of Un-audited Standalone and Consolidated Financial Results for the quarter and half financial year ended 30th September 2025 which appeared in Financial Express (English) all over India edition and Loksatta (Marathi) Mumbai edition on Thursday 13th November 2025.

Board Meeting Outcome for Outcome Of Board Meeting

12-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that Board of Directors of the Company at its Meeting held on Wednesday 12th November 2025 at the Registered Office of the Company at 301 Sumer Kendra P.B. Marg Worli Mumbai - 400 018 inter alia approved the following : 1. Un-audited Standalone and Consolidated Financial Results for the quarter and half financial year ended 30th September 2025 along with the Limited Review Report issued by M/s. A H J & Associates Chartered Accountants Statutory Auditor of the Company. 2. Standalone and Consolidated Statement of Assets and Liabilities for the half financial year ended 30th September 2025. 3. Standalone and Consolidated Cash Flow Statement for the half financial year ended 30th September 2025